Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

177
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
177
Measurement of Bioavailability: Pharmacodynamic Methods01:20

Measurement of Bioavailability: Pharmacodynamic Methods

21
Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
21
Model Approaches for Pharmacokinetic Data: Physiological Models01:15

Model Approaches for Pharmacokinetic Data: Physiological Models

140
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
140
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

1.4K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
1.4K
Preclinical Development: Overview01:28

Preclinical Development: Overview

5.3K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.3K

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Microphysiological systems to accelerate and de-risk AAV gene therapy development.

Advanced drug delivery reviews·2026
Same author

Creating a roadmap to fast-track human-centric non-animal methodologies via innovative funding mechanisms and strategic partnerships.

ALTEX·2026
Same author

Autologous Organoid-T Cell Co-Culture Platform for Modeling of Immune-Mediated Drug-Induced Liver Injury.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2025
Same author

In silico & in vitro approaches suggest osteoclastogenesis induction underlying fractures in Entrectinib-treated children.

Archives of toxicology·2025
Same author

Preclinical B cell depletion and safety profile of a brain-shuttled crystallizable fragment-silenced CD20 antibody.

Clinical and translational medicine·2025
Same author

Biology-inspired dynamic microphysiological system approaches to revolutionize basic research, healthcare and animal welfare.

ALTEX·2025
Same journal

Erratum for the Research Article "Detecting supramolecular organic nanoparticles during heat wave".

Science (New York, N.Y.)·2026
Same journal

Local signals, systemic decline.

Science (New York, N.Y.)·2026
Same journal

The mechanics of liver regeneration.

Science (New York, N.Y.)·2026
Same journal

Computing in a memory with physics.

Science (New York, N.Y.)·2026
Same journal

Retraction.

Science (New York, N.Y.)·2026
Same journal

Making time.

Science (New York, N.Y.)·2026
関連記事をすべて見る

関連する実験動画

Updated: Oct 20, 2025

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment
08:59

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment

Published on: December 3, 2020

8.1K

薬の開発のためのヒトの微生理系

Adrian Roth1, 2

  • 1F. Hoffmann-La Roche Ltd., Personalized Healthcare Safety, Product Development Safety, Roche Innovation Center, Basel, Switzerland.

Science (New York, N.Y.)
|September 16, 2021
PubMed
まとめ
この要約は機械生成です。

臓器チップは 薬の有効性を評価する 新しい方法を提供します この技術は パーソナライズされた医療の進歩と 個々の患者に合わせた治療の 実現に寄与します

さらに関連する動画

Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro
11:06

Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro

Published on: January 31, 2022

4.9K
Automated Contraction Analysis of Human Engineered Heart Tissue for Cardiac Drug Safety Screening
10:39

Automated Contraction Analysis of Human Engineered Heart Tissue for Cardiac Drug Safety Screening

Published on: April 15, 2017

13.1K

関連する実験動画

Last Updated: Oct 20, 2025

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment
08:59

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment

Published on: December 3, 2020

8.1K
Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro
11:06

Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro

Published on: January 31, 2022

4.9K
Automated Contraction Analysis of Human Engineered Heart Tissue for Cardiac Drug Safety Screening
10:39

Automated Contraction Analysis of Human Engineered Heart Tissue for Cardiac Drug Safety Screening

Published on: April 15, 2017

13.1K

科学分野:

  • 生物医学工学
  • 薬物の発見
  • パーソナライズ された 医療

背景:

  • 薬剤検査の伝統的な方法は 人間の反応を予測する上で 限界に直面しています
  • 薬の開発パイプラインの改善には,先進的なin vitroモデルの開発が不可欠です.
  • 臓器チップは 人間の生理学を模倣する上で 重要な進歩です

研究 の 目的:

  • 薬物有効性の評価のための臓器チップ技術の可能性を探求する.
  • パーソナライズド医療における 臓器チップの応用を調査する
  • 臓器チップモデルが従来の方法よりも優れていることを強調する.

主な方法:

  • 微流体装置を使って 細胞や組織を培養する
  • 人間の臓器の構造と機能を再現する
  • 細胞反応のリアルタイムモニタリングと分析を統合する.

主要な成果:

  • 臓器チップは 人間の臓器機能の 重要な側面を成功裏に真似ています
  • より高い精度で薬剤反応を予測する可能性があることが示されています.
  • 患者特有の薬物スクリーニングの有用性を示した.

結論:

  • 臓器チップは臨床前薬効性試験の 有望なツールです
  • この技術はパーソナライズド医療の実現に 大きく貢献できます
  • 薬の発見と臨床応用に 革命をもたらす可能性があります